Literature DB >> 24481117

Returning pleiotropic results from genetic testing to patients and research participants.

Jonathan M Kocarnik1, Stephanie M Fullerton2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24481117      PMCID： PMC3976043          DOI： 10.1001/jama.2014.369

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.

Authors:  Gabrielle M Christenhusz; Koenraad Devriendt; Kris Dierickx
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

Review 2.  Ancillary risk information and pharmacogenetic tests: social and policy implications.

Authors:  N B Henrikson; W Burke; D L Veenstra
Journal:  Pharmacogenomics J       Date:  2007-05-08       Impact factor: 3.550

Review 3.  The pleiotropic structure of the genotype-phenotype map: the evolvability of complex organisms.

Authors:  Günter P Wagner; Jianzhi Zhang
Journal:  Nat Rev Genet       Date:  2011-03       Impact factor: 53.242

4.  The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery.

Authors:  S A Pendergrass; K Brown-Gentry; S M Dudek; E S Torstenson; J L Ambite; C L Avery; S Buyske; C Cai; M D Fesinmeyer; C Haiman; G Heiss; L A Hindorff; C-N Hsu; R D Jackson; C Kooperberg; L Le Marchand; Y Lin; T C Matise; L Moreland; K Monroe; A P Reiner; R Wallace; L R Wilkens; D C Crawford; M D Ritchie
Journal:  Genet Epidemiol       Date:  2011-05-18       Impact factor: 2.135

5.  The question not asked: the challenge of pleiotropic genetic tests.

Authors:  Robert Wachbroit
Journal:  Kennedy Inst Ethics J       Date:  1998-06

Review 6.  Pleiotropy in complex traits: challenges and strategies.

Authors:  Nadia Solovieff; Chris Cotsapas; Phil H Lee; Shaun M Purcell; Jordan W Smoller
Journal:  Nat Rev Genet       Date:  2013-06-11       Impact factor: 53.242

Review 7.  Abundant pleiotropy in human complex diseases and traits.

Authors:  Shanya Sivakumaran; Felix Agakov; Evropi Theodoratou; James G Prendergast; Lina Zgaga; Teri Manolio; Igor Rudan; Paul McKeigue; James F Wilson; Harry Campbell
Journal:  Am J Hum Genet       Date:  2011-11-11       Impact factor: 11.025

8.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822
  8 in total
  21 in total

1.  Which Results to Return: Subjective Judgments in Selecting Medically Actionable Genes.

Authors:  Gabriel Lázaro-Muñoz; John M Conley; Arlene M Davis; Anya E R Prince; R Jean Cadigan
Journal:  Genet Test Mol Biomarkers       Date:  2017-02-01

2.  Compare and contrast: a cross-national study across UK, USA and Greek experts regarding return of incidental findings from clinical sequencing.

Authors:  Elli G Gourna; Natalie Armstrong; Susan E Wallace
Journal:  Eur J Hum Genet       Date:  2015-06-10       Impact factor: 4.246

3.  Ethical signposts for clinical geneticists in secondary variant and incidental finding disclosure discussions.

Authors:  Gabrielle M Christenhusz; Koenraad Devriendt; Hilde Van Esch; Kris Dierickx
Journal:  Med Health Care Philos       Date:  2015-08

4.  Pediatric Issues in Return of Results and Incidental Findings: Weighing Autonomy and Best Interests.

Authors:  Ingrid A Holm
Journal:  Genet Test Mol Biomarkers       Date:  2017-01-31

5.  Genetic information, non-discrimination, and privacy protections in genetic counseling practice.

Authors:  Anya E R Prince; Myra I Roche
Journal:  J Genet Couns       Date:  2014-07-27       Impact factor: 2.537

6.  Evidence for extensive pleiotropy among pharmacogenes.

Authors:  Matthew T Oetjens; William S Bush; Joshua C Denny; Kelly Birdwell; Nuri Kodaman; Anurag Verma; Holli H Dilks; Sarah A Pendergrass; Marylyn D Ritchie; Dana C Crawford
Journal:  Pharmacogenomics       Date:  2016-06-01       Impact factor: 2.533

7.  Powerful and robust cross-phenotype association test for case-parent trios.

Authors:  S Taylor Fischer; Yunxuan Jiang; K Alaine Broadaway; Karen N Conneely; Michael P Epstein
Journal:  Genet Epidemiol       Date:  2018-02-20       Impact factor: 2.135

8.  Identification of variants in pleiotropic genes causing "isolated" premature ovarian insufficiency: implications for medical practice.

Authors:  Elena J Tucker; Sonia R Grover; Gorjana Robevska; Jocelyn van den Bergen; Chloe Hanna; Andrew H Sinclair
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

Review 9.  Biobanks and personalized medicine.

Authors:  J E Olson; S J Bielinski; E Ryu; E M Winkler; P Y Takahashi; J Pathak; J R Cerhan
Journal:  Clin Genet       Date:  2014-03-27       Impact factor: 4.438

10.  Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.

Authors:  Kurt D Christensen; J Scott Roberts; Peter J Whitehouse; Charmaine D M Royal; Thomas O Obisesan; L Adrienne Cupples; Jacqueline A Vernarelli; Deepak L Bhatt; Erin Linnenbringer; Melissa B Butson; Grace-Ann Fasaye; Wendy R Uhlmann; Susan Hiraki; Na Wang; Robert Cook-Deegan; Robert C Green
Journal:  Ann Intern Med       Date:  2016-01-26       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.